Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuderer

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
JAMA Oncology|September 2, 2021
COVID-19 and Cancer: A Review of the Registry-Based Pandemic ResponseAakash Desai, Turab J Mohammed, Narjust Duma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineLyndsay N Harris, Nofisat Ismaila, Lisa M McShane, et al.
Journal of the National Cancer Institute|February 16, 2026
Sex-based prognosis in industry-sponsored advanced solid tumour trials: an individual participant data meta-analysis of survival and adverse eventsRakchha Chhetri, Natansh D Modi, Bradley D Menz, et al.
Thrombosis and Haemostasis|September 22, 2017
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI TrialAlok A Khorana, Saroj Vadhan-Raj, Nicole M Kuderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2023
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline UpdateNigel S Key, Alok A Khorana, Nicole M Kuderer, et al.
International Journal of Cancer|June 21, 2025
Patient-reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trialsBradley D Menz, Natansh D Modi, Ahmad Y Abuhelwa, et al.
Cancer Medicine|October 30, 2025
Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast CancerNatansh D Modi, Ahmad Y Abuhelwa, Nicole M Kuderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2019
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline UpdateNigel S Key, Alok A Khorana, Nicole M Kuderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2013
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline updateGary H Lyman, Alok A Khorana, Nicole M Kuderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2022
Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE TrialMina S Sedrak, Can-Lan Sun, Jingran Ji, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
JAMA Oncology|September 2, 2021
COVID-19 and Cancer: A Review of the Registry-Based Pandemic ResponseAakash Desai, Turab J Mohammed, Narjust Duma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineLyndsay N Harris, Nofisat Ismaila, Lisa M McShane, et al.
Journal of the National Cancer Institute|February 16, 2026
Sex-based prognosis in industry-sponsored advanced solid tumour trials: an individual participant data meta-analysis of survival and adverse eventsRakchha Chhetri, Natansh D Modi, Bradley D Menz, et al.
Thrombosis and Haemostasis|September 22, 2017
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI TrialAlok A Khorana, Saroj Vadhan-Raj, Nicole M Kuderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2023
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline UpdateNigel S Key, Alok A Khorana, Nicole M Kuderer, et al.
International Journal of Cancer|June 21, 2025
Patient-reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trialsBradley D Menz, Natansh D Modi, Ahmad Y Abuhelwa, et al.
Cancer Medicine|October 30, 2025
Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast CancerNatansh D Modi, Ahmad Y Abuhelwa, Nicole M Kuderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2019
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline UpdateNigel S Key, Alok A Khorana, Nicole M Kuderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2013
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline updateGary H Lyman, Alok A Khorana, Nicole M Kuderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2022
Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE TrialMina S Sedrak, Can-Lan Sun, Jingran Ji, et al.
Pageof 13